While BRAF-mutated melanoma acquires drug resistance when HuR is overexpressed [108], lithium was demonstrated to suppress the proliferation of HuR-expressed cells and alleviate drug resistance [108]. This evidence concerns the gene ELAVL1 and melanoma.